Ticker
RNXTCompany Name
RENOVORX INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -11M | -1661.18% | $ 662K |
3/31/2025 | $ -10.51M | -4380% | $ 240K |
12/31/2024 | $ -9.19M | -21374.42% | $ 43K |
9/30/2024 | $ -9.05M | 0% | $ 0 |
6/30/2024 | $ -8.01M | 0% | $ 0 |
3/31/2024 | $ -7.94M | 0% | $ 0 |
12/31/2023 | $ -10.12M | 0% | $ 0 |
9/30/2023 | $ -9.18M | 0% | $ 0 |
6/30/2023 | $ -9.91M | 0% | $ 0 |
3/31/2023 | $ -10.2M | 0% | $ 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA / Revenues
(=) EBITDA %
EBITDA % for RENOVORX INC is calculated as follows: EBITDA [ $ -3.21M ] / Revenues [ $ 0 ]
(=) EBITDA % [ 0% ]
Minimum
Dec 31, 2024
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.29K |
---|---|
min | -74.33% |
max | 97.24% |
average | 16.2% |
median | 14.74% |
std | 26.73% |